Delivery Order SPE2DR25D7061-SPE2DR26F7WRT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Clindamycin (Pediatric) 75 mg/5 mL in 100 mL quantities, valued at $1,283.69. This non-set-aside, competitively awarded contract operates under a firm fixed-price arrangement with an ultimate completion date of August 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction...
- The Defense Logistics Agency awarded a $1,427.76 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Clindamycin (pediatric) 75 mg/5 ml in 100 ml quantities, with a completion date of December 11, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle that extends through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Clindamycin (pediatric formulation) 75 mg/5 ml in 100 ml quantities, with a ceiling value of $1,865.88. This firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized competitive procurement procedures with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Clindamycin (Pediatric) 75 mg/5 mL in 100 mL quantities, with a ceiling value of $1,743.23. This contract is structured as a firm fixed price delivery order with an ultimate completion date of June 23, 2025, and was competitively awarded without set-aside provisions. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,829.11 delivery order to AmerisourceBergen Drug Corp for Clindamycin Palmitate, an antibiotic pharmaceutical product. This firm fixed price delivery order, issued on December 5, 2025, is scheduled for completion by January 5, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive set-aside arrangement, reflecting AmerisourceBergen's established position as a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin PH 900 mg/6 ml vials on June 17, 2025, with a ceiling value of $1,347.33. This is a firm fixed-price delivery order with an ultimate completion date of June 18, 2025, reflecting the time-sensitive nature of pharmaceutical procurement for military and federal healthcare operations. The contract carries no set-aside designation, indicating it was awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Clindamycin PH 1% Solution in 60ML quantities, with a contract ceiling value of $1,179.36. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 3,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,401.76 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% Dextrose solution. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 23, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the company's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 mL in dextrose 5% water solution on August 26, 2025, with a ceiling value of $6,902.86. This firm fixed-price delivery order is not set-aside and represents a single transaction within AmerisourceBergen's larger federal pharmaceutical supply portfolio. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $2,117.43 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Clindamycin 900 mg/50 mL in dextrose 5% water solution. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D7061Indefinite Delivery Contract
- SPE2DR25D7061-SPE2DR26F7WRTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Clindamycin (Pediatric) 75 mg/5 mL in 100 mL quantities, with a ceiling value of $3,750.83 and a completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a major distribution center for pharmaceutical products. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including critical medications, vaccines, and specialized medical commodities. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in meeting federal procurement requirements through open competition across multiple therapeutic domains and product categories serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 12/3/25 |